Conditions: NSCLC Adenocarcinoma; Gastroesophageal Cancer (GC); Gastric Adenocarcinoma; Adenocarcinoma of Esophagus; Squamous Cell Car. – Esophagus; Urothelial Carcinoma (UC); Bladder Cancer; Mesothelioma; Pleural Mesothelioma; Peritoneal Mesothelioma; Non-Small Cell Lung Cancer NSCLC
Interventions: Drug: IDE892; Drug: IDE397
Sponsors: IDEAYA Biosciences
**RECRUITING NOW**
Interventions: Drug: IDE892; Drug: IDE397
Sponsors: IDEAYA Biosciences
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
